Prescription medication · Beta-Blocker with ISA

pindolol

Also sold as Visken. Pindolol treats high blood pressure.

Data updated 2026-05-15

774
FDA reportsRarely reported
4
InteractionsFew interactions
In shortage
FDA status

What the data shows

pindolol (Visken) is a prescription Beta-Blocker with ISA, among the least-reported drugs the FDA tracks (774 FDA reports), with 4 documented drug interactions.

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

pindolol (Visken) is a prescription Beta-Blocker with ISA. Pindolol treats high blood pressure.

Pindolol is a medicine that lowers high blood pressure. It belongs to a class of drugs called beta-blockers.

Drug Shortage Alert

pindolol is currently listed as to be discontinued by the FDA. Affected manufacturer: Sun Pharmaceutical Industries, Inc..

View all drug shortages →

Drug Pricing (NADAC)

Generic Price

$0.79/unit

Generic Available

Yes (4 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

Compare with Another Drug → Full Side Effects Report →

What it does

Pindolol treats high blood pressure.

Common side effects

Bizarre or many dreams, Dizziness, Fatigue

Key warnings

You should not take pindolol if you have asthma, heart failure, cardiogenic shock, second or third-degree heart block, or a very slow heart rate.

The sections below are summarized in plain English from pindolol's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Pindolol blocks the effects of certain natural chemicals in your body, like adrenaline. This helps to slow down your heart rate and lower your blood pressure. It also has some stimulating activity of its own.

Side Effects (from patient reports)

Based on 774 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for pindolol, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for pindolol each year to the FDA Adverse Event Reporting System (FAERS).

020406080 20042007201020132016201920222025 20

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where pindolol sits

pindolol has more FDA adverse-event reports than 5% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is pindolol; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 774 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

774

Reports Mentioning Death

63

8.1% of reports — not proof of cause

Hospitalization Reports

261

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 489 (66%)
Male 249 (34%)

Age Distribution

0–17 10
18–44 86
45–64 127
65–74 90
75+ 168

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
2 FATIGUE 43
3 NAUSEA 43
4 URINARY TRACT INFECTION 42
5 DIZZINESS 41
6 DRUG INTERACTION 40
7 DYSPNOEA 40
8 FALL 31
9 DIARRHOEA 30
10 RHABDOMYOLYSIS 28
11 PAIN 26
12 HEADACHE 25
13 MUSCULAR WEAKNESS 24
14 MYALGIA 24
15 SEPSIS 24
16 DEPRESSION 22

Reactions in Death Reports

DEATH 19
COMPLETED SUICIDE 11
TOXICITY TO VARIOUS AGENTS 6
ACUTE KIDNEY INJURY 5
AGRANULOCYTOSIS 3
CARDIAC ARREST 3
DYSPNOEA 3
SEPTIC SHOCK 3
ANAEMIA 2
ARRHYTHMIA 2

Reactions in Hospitalization Reports

DRUG INTERACTION 26
RHABDOMYOLYSIS 21
FALL 18
PNEUMONIA 18
MUSCULAR WEAKNESS 15
URINARY TRACT INFECTION 15
DYSPNOEA 14
MYALGIA 13
CHROMATURIA 12
HYPOTENSION 12

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

You should not take pindolol if you have asthma, heart failure, cardiogenic shock, second or third-degree heart block, or a very slow heart rate.

Known Drug Interactions

Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.

Mechanism: These drugs are often used together to lower blood pressure without causing any unexpected problems. They work in different ways to help your heart and blood vessels.

Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.

Mechanism: These two blood pressure medicines can be used together safely. They do not have any harmful interactions when taken at the same time.

Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reactions.

Mechanism: Pindolol can block the action of epinephrine, which is used to treat severe allergic reactions. This means the usual dose of epinephrine might not work as well as it should.

Drug Interactions Reduced cytochrome P450 2D6 isozyme activity, drugs which inhibit this isozyme (e.g., fluoxetine and paroxetine), and certain other drugs (e.g., fluvoxamine, propranolol, and pindolol) appear to appreciably inhibit the metabolism of thioridazine. Pindolol Concurrent administration of pindolol and thioridazine have resulted in moderate, dose related increases in the serum levels of thioridazine and two of its metabolites, as well as higher than expected serum pindolol levels. Pindolol and thioridazine should not be coadministered.

Mechanism: These two drugs block each other from being cleared out of your system. This leads to higher levels of both drugs in your blood than your doctor intended.

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

How quickly will pindolol lower my blood pressure?
You may see some effect within the first week. It may take up to 2 weeks or longer to see the full effect.
Can I stop taking pindolol suddenly?
Talk to your doctor before stopping pindolol. Stopping suddenly can cause problems.
Will pindolol affect my ability to exercise?
Pindolol can lower your heart rate, so you may not be able to exercise as intensely. Talk to your doctor about safe exercise levels.
Can I drink alcohol while taking pindolol?
Alcohol can lower your blood pressure, which could increase the effect of pindolol. Talk to your doctor about drinking alcohol while taking this medicine.
Does pindolol interact with other medications?
Yes, pindolol can interact with other medications. Tell your doctor about all the medicines you take, including over-the-counter drugs and supplements.
What should I do if I feel dizzy while taking pindolol?
If you feel dizzy, sit or lie down. Avoid sudden changes in position.
Can pindolol cause weight gain?
Weight gain is a possible side effect, but it is not common.
Will pindolol cure my high blood pressure?
Pindolol helps to control high blood pressure, but it is usually not a cure. You may need to take it long-term.
Can pindolol cause depression?
Depression is a possible side effect, but it is not common. Tell your doctor if you experience changes in your mood.
What if my allergies get worse while taking Pindolol?
While taking beta blockers, patients with a history of severe allergic reaction may be more reactive to repeated exposure. Such patients may not respond to standard doses of epinephrine.
What are the common side effects of pindolol?
The registry lists Bizarre or many dreams, Dizziness, Fatigue, Insomnia, Nervousness among the most-reported FAERS reaction terms for pindolol. The compiled record contains 774 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does pindolol interact with other medications?
The registry has 4 documented interaction rows for pindolol. Notable source-record pairings include hydrochlorothiazide, hydralazine, epinephrine. These rows are not a complete medication review.
What drug class is pindolol?
pindolol belongs to the Beta-Blocker with ISA drug class. It requires a prescription (Rx). Pindolol treats high blood pressure.
What pregnancy or breastfeeding source fields are listed for pindolol?
The FDA label for pindolol contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.
Is pindolol currently in shortage?
Yes, pindolol is currently listed as to be discontinued by the FDA. Affected manufacturer: Sun Pharmaceutical Industries, Inc.. Visit the FDA Drug Shortages database for the latest updates.

Other drugs grouped near pindolol - same-class peers and common alternatives.

Compare pindolol vs acebutolol side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for pindolol: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on pindolol

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for pindolol

The FDA label for pindolol (sold under brand names such as Visken) classifies it as a prescription-only medication in the Beta-Blocker with ISA class. Pindolol treats high blood pressure. Official labeling lists 10 commonly reported side effects, including Bizarre or many dreams, Dizziness, Fatigue.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 774 voluntary reports. The database also lists 4 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $0.79.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC). Shortage status: FDA Drug Shortages Database.

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: October 9, 2025

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page